These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21326611)

  • 41. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises.
    Sarmento LM; Barata JT
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1403-15. PubMed ID: 21929314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
    Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
    Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
    Weng AP; Millholland JM; Yashiro-Ohtani Y; Arcangeli ML; Lau A; Wai C; Del Bianco C; Rodriguez CG; Sai H; Tobias J; Li Y; Wolfe MS; Shachaf C; Felsher D; Blacklow SC; Pear WS; Aster JC
    Genes Dev; 2006 Aug; 20(15):2096-109. PubMed ID: 16847353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines.
    Cecchinato V; Erba E; Basile A; Scarpati B; Fazi C; Brando B; Comi P; Chiaramonte R
    Leuk Res; 2008 May; 32(5):791-7. PubMed ID: 17964649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances on NOTCH signaling in T-ALL.
    Tzoneva G; Ferrando AA
    Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NOTCH1-induced T-cell leukemia in transgenic zebrafish.
    Chen J; Jette C; Kanki JP; Aster JC; Look AT; Griffin JD
    Leukemia; 2007 Mar; 21(3):462-71. PubMed ID: 17252014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
    Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
    Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.
    Zweier-Renn LA; Riz I; Hawley TS; Hawley RG
    J Bone Marrow Res; 2013 Feb; 1():. PubMed ID: 25309961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia.
    Saccomani V; Grassi A; Piovan E; Bongiovanni D; Di Martino L; Minuzzo S; Tosello V; Zanovello P
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
    Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
    Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TLX1/HOX11-induced hematopoietic differentiation blockade.
    Riz I; Akimov SS; Eaker SS; Baxter KK; Lee HJ; Mariño-Ramírez L; Landsman D; Hawley TS; Hawley RG
    Oncogene; 2007 Jun; 26(28):4115-23. PubMed ID: 17213805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
    Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene.
    Greene WK; Sontani Y; Sharp MA; Dunn DS; Kees UR; Bellgard MI
    Gene; 2007 Apr; 391(1-2):223-32. PubMed ID: 17303350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models.
    Loontiens S; Vanhauwaert S; Depestel L; Dewyn G; Van Loocke W; Moore FE; Garcia EG; Batchelor L; Borga C; Squiban B; Malone-Perez M; Volders PJ; Olexiouk V; Van Vlierberghe P; Langenau DM; Frazer JK; Durinck K; Speleman F
    Leukemia; 2020 Dec; 34(12):3398-3403. PubMed ID: 32591643
    [No Abstract]   [Full Text] [Related]  

  • 55. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
    Kleppe M; Soulier J; Asnafi V; Mentens N; Hornakova T; Knoops L; Constantinescu S; Sigaux F; Meijerink JP; Vandenberghe P; Tartaglia M; Foa R; Macintyre E; Haferlach T; Cools J
    Blood; 2011 Jun; 117(26):7090-8. PubMed ID: 21551237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis.
    Funahashi Y; Hernandez SL; Das I; Ahn A; Huang J; Vorontchikhina M; Sharma A; Kanamaru E; Borisenko V; Desilva DM; Suzuki A; Wang X; Shawber CJ; Kandel JJ; Yamashiro DJ; Kitajewski J
    Cancer Res; 2008 Jun; 68(12):4727-35. PubMed ID: 18559519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of TLX1 gene polymorphisms with the risk of acute lymphoblastic leukemia and B lineage acute lymphoblastic leukemia in Han Chinese children.
    Mei E; Wei X; Gao J; Tian X; Li W; Liu L; Qian C
    J Clin Lab Anal; 2020 Sep; 34(9):e23414. PubMed ID: 32488880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.
    Palomero T; Ferrando A
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S205-10. PubMed ID: 19778842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.
    Tan Y; Sementino E; Xu J; Pei J; Liu Z; Ito TK; Cai KQ; Peri S; Klein-Szanto AJ; Wiest DL; Testa JR
    Oncotarget; 2017 Feb; 8(9):14941-14956. PubMed ID: 28122332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells.
    Nagel S; Venturini L; Przybylski GK; Grabarczyk P; Meyer C; Kaufmann M; Battmer K; Schmidt CA; Drexler HG; Scherr M; Macleod RA
    BMC Cancer; 2009 Oct; 9():371. PubMed ID: 19835636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.